Contact Us

Contact us with any questions or comments regarding our novel approach to treating infectious, inflammatory, and degenerative diseases with our plasma gelsolin technology platform.

Name

Email

Phone

Organization

Role

Scientist/Academic Media Investor Other

Message

Stay informed of our latest discoveries and news.

EMAIL

GENERAL NEWS/MEDIA

Clinical Trials Arena Award -
Best Covid 19 Response
February 2021

March 2022: BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction

March 22, 2022

February 2022: BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members

February 17, 2022

January 2022: BioAegis’ Novel Host-directed Human Protein for Inflammatory Diseases Geared for Growth in 2022

January 24, 2022

EVENTS

November 12, 2021: Belgium MACRO Trends Investors Conference

October 6-7, 2020: BioNJ’s 10th Annual BioPartnering Conference

Tweets by BioAegis

COMPANY DETAILS

LOCATION:
BioAegis Therapeutics
North Brunswick, NJ

MEDIA INQUIRIES:
Contact: Christine Lagana
clagana@bioaegistx.com

INVESTOR INQUIRIES:
Contact: Steven Cordovano
scordovano@bioaegistx.com

Contact Us

Stay informed of our latest discoveries and news.

GENERAL NEWS/MEDIA

March 2022: BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction

February 2022: BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members

January 2022: BioAegis’ Novel Host-directed Human Protein for Inflammatory Diseases Geared for Growth in 2022

EVENTS

November 12, 2021: Belgium MACRO Trends Investors Conference

October 6-7, 2020: BioNJ’s 10th Annual BioPartnering Conference

COMPANY DETAILS

JOIN OUR TEAM

PRODUCT FAQS

FOLLOW US